Latest

Latest AusBiotech News | Page 8

  • Latest AusBiotech news stories and updates. What is happening today? All recent AusBiotech news and developments. Live coverage and timeline of AusBiotech. All you need to know about AusBiotech.
AusBiotech advocates for sustainable funding model for TGA
FDA approves IND for Prader-Willi syndrome study of Neuren’s NNZ-2591
NSW launches Biosciences Fund to boost state’s world-class innovators
Chimeric Therapeutics updates on CLTX CAR T clinical trial
US recruitment milestone for trial of Immuron’s Travelan
AusBiotech’s draft National Reconstruction Fund submission open for comment
New Year’s resolutions for healthy future
Dimerix confirms the outcomes of a meeting with the FDA on paediatric plan for DMX-200
LBT Innovations subsidiary appoints APAS Independence distributor for Europe
Dimerix completes recruitment in first part of DMX-200 trial
Bionomics reports topline results in PREVAIL study of BNC210
AusBiotech office closure 20 December
ARCS Signature Program launched for senior leaders
Major industry award for Australian scientist at forefront of genetic breast cancer research
CSL announces appointment of its new CEO and managing director
Novotech awarded Asia Pacific CRO of Year 2022 for ‘Best Practices in Clinical Trials’
CSL opens its new ‘Australian Plasma Fractionation Facility’ in Melbourne
Nominations open for PM’s Prizes for Science
Noxopharm provides update on trial of its oncology drug candidate
Vaxxas appoints Doug Cubbin as its new chief financial officer
Contributions now open for upcoming Australasian Biotechnology’
Pre-clinical data for Kazia Therapeutics’ EVT801 published in cancer journal
WEHI scientist recognised with CSL Florey Medal for malaria research
Developer announces plans for new medical research facility in Brisbane
National Reconstruction Fund takes step forward
Immutep announces new collaboration for cancer treatment combination
Emyria accepted into US National Institutes of Health research program
Sonic Healthcare takes major strategic stake in Microba
Artificial intelligence high on life sciences’ agenda
Australian venture capital fund joins partners in backing new immunotherapy
CSL secures US approval for breakthrough one-time haemophilia gene therapy
AusBiotech gets behind campaign to combat ‘silent pandemic’
IND approval from US FDA for theranostic SARBombesin trial in prostate cancer
Zelira Therapeutics announces successful enrolment in new trial Zelira Therapeutics
Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia
AusBiotech Policy Forum: Biotech leaders head to Parliament
AusBiotech connects sector to celebrate 2022
Telix acquires US radiochemistry business Optimal Tracers
Commercialisation key priority in future MRFF decisions
Brandon Capital Invests in neuroscience company NRG Therapeutics
BiomeBank announces world first regulatory approval for donor derived microbiome drug
QIMR and WEHI take home prizes for best early-stage project
Alterity Therapeutics updates on Multiple System Atrophy study
Telix announces positive topline results of late-stage imaging study
New AusBiotech Board fit for era
Federal Budget mostly ‘vanilla’, with bit of sting
Life sciences industry’s highest achievers celebrated at prestigious Awards ceremony
$5 million global challenge to boost health outcomes in Pilbara

© 2024 - The National Tribune Australia